Cargando…
When to start aripiprazole therapy in patients with bipolar mania
Aripiprazole is a third generation atypical antipsychotic with compelling evidence as a highly effective treatment option in the management of acute manic and mixed episodes of bipolar I disorders. It has a unique mode of action, acting as a partial agonist at dopamine D2 and D3, and serotonin 5-HT1...
Autores principales: | Sayyaparaju, Kiran Kumar, Grunze, Heinz, Fountoulakis, Kostas N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958500/ https://www.ncbi.nlm.nih.gov/pubmed/24648740 http://dx.doi.org/10.2147/NDT.S40066 |
Ejemplares similares
-
Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
por: Rezayat, Amir Akhavan, et al.
Publicado: (2014) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: Muzina, David J
Publicado: (2009) -
Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009) -
How Does Adding the DSM-5 Criterion Increased Energy/Activity for Mania Change the Bipolar Landscape?
por: Grunze, Anna, et al.
Publicado: (2021) -
Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009)